NIH-funded research R01 grant

Immune markers that predict who will get severe acute pancreatitis

Official title: Immune Signatures and Clinical Outcomes in Acute Pancreatitis

Funded at Ohio State University · NIH-11333744 · Data updated 2026-11-12

Researchers will measure immune system proteins in people admitted with acute pancreatitis to spot early signs of who may become severely ill.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionOhio State University
NIH-funded
Lab location1 site (Columbus, UNITED STATES)
Project startApril 4, 2023
Project endMarch 31, 2027
Funding year2026
Award (this year)$674,554
NIH project number5R01DK134698-04
Project IDNIH-11333744 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are adults recently admitted to the hospital with acute pancreatitis who can provide blood samples and clinical follow-up information.

Less likely to help

People without acute pancreatitis or those fully recovered before enrollment would not directly benefit from this study.

What this research studies

You would be followed after hospital admission for acute pancreatitis while researchers collect blood samples and clinical information at multiple hospitals. Lab tests will measure a panel of immune proteins (including angiopoietin-2, hepatocyte growth factor, interleukin-8, resistin, and TNF receptor-1) and researchers will use bioinformatics to find patterns linked to severe disease. The study is a prospective multi-center observational cohort designed to validate an early blood-marker panel and to explore immune pathways driving organ failure. Results could help doctors identify high-risk patients earlier and point to new treatment targets.

Why it matters

Potential benefit: If successful, this work could help doctors identify patients at high risk for severe pancreatitis earlier so they can receive closer monitoring or be offered targeted trials.

How similar studies have gone: Pilot work by the team found a multi-cytokine blood panel that predicted severe pancreatitis with high accuracy, but it needs multi-center validation.

Where this research is happening

  • Ohio State University
    Columbus, United States
    Active

Researchers

  • Principal investigator: Papachristou, Georgios I — Ohio State University
  • Study coordinator: Papachristou, Georgios I

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.